Area of research
Transplantation · Infectious Diseases
Research interest
Research interests include Renal Transplantation Outcomes and Treatments, Mesenchymal stem cell research, COVID-19 Clinical Research Studies, and SARS-CoV-2 and COVID-19 Research.
New Developments and Therapeutic Drug Monitoring Options in Costimulatory Blockade in Solid Organ Transplantation: A Systematic Critical Review.
Improving outcomes in kidney transplantation through advances in donor organ perfusion
Removing the physician from the equation: Patient-controlled, home-based therapeutic drug self-monitoring of tacrolimus.
Long-term Double-J stenting is superior to short-term Single-J stenting in kidney transplantation.
Favorable Living Donor Kidney Transplantation Outcomes within a National Kidney Exchange Program: A Propensity Score-Matching Analysis.
Erythropoietin delivery through kidney organoids engineered with an episomal DNA vector
Prediction of the Intra-T Lymphocyte Tacrolimus Concentration after Kidney Transplantation with Population Pharmacokinetic Modeling.
Mesenchymal stromal cell-derived membrane particles suppress kidney fibrosis.
Limited Risk of Microbial Contamination During Hypothermic and Normothermic Machine Perfusion of Donor Kidneys.
Erythropoietin delivery through kidney organoids engineered with an episomal DNA vector.
(Pro)renin, Erythropoietin, Vitamin D and Urodilatin Release From Human Donor Kidneys During Normothermic Machine Perfusion: Predictors of Early Post-Transplant Outcome?
Dietary intake of oxalic acid affects plasma oxalic acid concentration in patients with kidney failure.
Alemtuzumab Exposure and T Lymphocyte Depletion: A Population Pharmacokinetic-Pharmacodynamic Model of Alemtuzumab Induction Therapy for Kidney Transplantation.
Multiomic profiling of transplant glomerulopathy reveals a novel T-cell dominant subclass.
Post COVID-19 condition imposes significant burden in patients with advanced chronic kidney disease: A nested case-control study
Telemedicine for Kidney Transplant Recipients: Current State, Advantages, and Barriers.
Interactions of the Immune System with Human Kidney Organoids.
SARS-CoV-2-specific immune responses converge in kidney disease patients and controls with hybrid immunity.
Imlifidase Desensitization in HLA-incompatible Kidney Transplantation: Finding the Sweet Spot.
Mycophenolate mofetil hampers antibody responses to a broad range of vaccinations in kidney transplant recipients: Results from a randomized controlled study.
Kidney Transplant Outcome Following Donation After Euthanasia.
NMR metabolomics-guided DNA methylation mortality predictors.
Public Opinions on Removing Disincentives and Introducing Incentives for Organ Donation: Proposing a European Research Agenda.
Incidence and Severity of COVID-19 in Relation to Anti-Receptor-Binding Domain IgG Antibody Level after COVID-19 Vaccination in Kidney Transplant Recipients.
Repeated COVID-19 Vaccination Drives Memory T- and B-cell Responses in Kidney Transplant Recipients: Results From a Multicenter Randomized Controlled Trial.
Anti-HLA Class II Antibodies Are the Most Resistant to Desensitization in Crossmatch-positive Living-donor Kidney Transplantations: A Patient Series.
Multicenter, Real-World Clinical Evaluation of Alemtuzumab and Anti-Thymocyte Globulin for Severe Acute T Cell-Mediated Kidney Transplant Rejection.
The effect of COVID-19 vaccination on kidney function and HLA antibody formation in patients with end-stage kidney disease and on kidney replacement treatment.
Allogenic MSC infusion in kidney transplantation recipients promotes within 4 hours distinct B cell and T cell phenotypes.
Allogeneic mesenchymal stromal cell therapy in kidney transplantation: should repeated human leukocyte antigen mismatches be avoided?